Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member
(NasdaqGM:LNTH),(NasdaqGM:LNTH), BEDFORD, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Phuong Khanh (P.K.) Morrow, M.D. to Lantheus' Board of Directors (“Board”), effective February 1, 2025. Dr. […]